Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial-Reference-Cited by-同舟云学术

Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trial

Published:2022-12 Issue:12 Volume:7 Page:1092-1102
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Schilsky Michael L,Czlonkowska Anna,Zuin Massimo,Cassiman David,Twardowschy Carlos,Poujois Aurelia,Gondim Francisco de Assis A,Denk Gerald,Cury Rubens G,Ott Peter,Moore Joanna,Ala Aftab,D'Inca Renata,Couchonnal-Bedoya Eduardo,D'Hollander Koenraad,Dubois Nicolas,Kamlin C Omar F,Weiss Karl Heinz,To Uyen,Patel Amar,Hettiarachchi Daksshi,Giorgini Alessia,Monico Sara,Litwin Tomasz,Piechal Agnieszka,Skowronska Marta,Lachaux Alain,Belmalih Abdelouahed,Boogers Alexandra,Mohr Isabelle,Langel Andrea,Freitas Christian,Barbosa Egberto Reis,Sandahl Thomas D,Gerdes Lisbet,Obadia Alexandre,Rahli Djamila,Cosgrove Jeremy

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference33 articles.

1. Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver;Wilson;Brain,1912

2. The prevalence of Wilson's disease: an update;Sandahl;Hepatology,2020

3. Wilson's disease;Ala;Lancet,2007

4. Diagnosis and treatment of Wilson disease: an update;Roberts;Hepatology,2008

5. A critical evaluation of copper metabolism in Indian Wilson's disease children with special reference to their phenotypes and relatives;Prasad;Biol Trace Elem Res,1998

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comparative analysis in monitoring 24-hour urinary copper in Wilson Disease: Sampling on or off treatment?;2024-09-10

2. Gandouling ameliorates liver injury in Wilson's disease through the inhibition of ferroptosis by regulating the HSF1/HSPB1 pathway;Journal of Cellular and Molecular Medicine;2024-09

3. Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets;JHEP Reports;2024-08

4. Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson’s Disease;Cells;2024-07-18

5. Metabolic stress-induced dysregulation of the Hippo signaling pathway inhibits the occurrence of hepatocarcinoma;2024-05-14